BRIDGEWAY CAPITAL MANAGEMENT, LLC - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 39 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$445,560
+3.3%
112,800
-18.1%
0.01%
+10.0%
Q2 2023$431,314
-30.9%
137,8000.0%0.01%
-41.2%
Q1 2023$624,234
+140.7%
137,800
+119.4%
0.02%
+142.9%
Q4 2022$259,364
-33.3%
62,800
-48.4%
0.01%
-30.0%
Q3 2022$389,000
+63.4%
121,5990.0%0.01%
+100.0%
Q2 2022$238,000
-6.3%
121,599
+93.6%
0.01%0.0%
Q1 2022$254,000
-62.5%
62,8000.0%0.01%
-61.5%
Q4 2021$678,000
+132.2%
62,800
+214.0%
0.01%
+160.0%
Q1 2021$292,000
+88.4%
20,000
+95.1%
0.01%
+25.0%
Q3 2020$155,00010,2500.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$32,439,0009.14%
ACUTA CAPITAL PARTNERS, LLC 863,100$18,479,0005.03%
SILVERARC CAPITAL MANAGEMENT, LLC 217,203$4,650,0002.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$110,145,0002.18%
Atlas Venture Advisors, Inc. 292,184$6,256,0001.40%
Logos Global Management LP 715,000$15,308,0001.31%
Sio Capital Management, LLC 188,661$4,039,0000.83%
Vivo Capital, LLC 799,662$17,121,0000.76%
Altium Capital Management LP 93,261$1,997,0000.75%
RA Capital Management 1,515,151$32,439,0000.45%
View complete list of LARIMAR THERAPEUTICS INC shareholders